Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J3489
    Short Description Zoledronic acid 1mg
    Long Description Injection, zoledronic acid, 1 mg
    Pricing indicator 51
    Coverage code C
    ASC payment group code
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 2018-01-01
    Date Added 2014-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00078043561 J3489 Zoledronic acid 1mg Reclast NOVARTIS PHARMACEUTICALS CORPORATION 1 MG 100 1 5 5
    00409421501 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID PFIZER INC. 1 MG 5 1 4 4
    16714081501 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID NORTHSTAR RX LLC 1 MG 5 1 4 4
    16729024231 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID ACCORD HEALTHCARE INC. 1 MG 5 1 4 4
    25021080166 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID SAGENT PHARMACEUTICALS INC 1 mg 5 1 4 4
    25021082667 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID SAGENT PHARMACEUTICALS INC 1 MG 100 1 4 4
    25021082682 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID SAGENT PHARMACEUTICALS INC 1 MG 100 1 4 4
    25021083082 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID SAGENT PHARMACEUTICALS INC 1 MG 100 1 5 5
    43598023311 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID DR.REDDY'S LABORATORIES, INC. 1 MG 5 1 4 4
    50742041605 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID INGENUS PHARMACEUTICALS, LLC 1 MG 5 1 4 4
    51991006498 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID BRECKENRIDGE PHARMACEUTICAL 1 MG 100 1 5 5
    51991006598 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID BRECKENRIDGE PHARMACEUTICAL 1 MG 5 1 4 4
    55111068507 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID DR. REDDY'S LABORATORIES, INC. 1 mg 5 1 4 4
    55111068852 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID DR. REDDY'S LABORATORIES, INC. 1 MG 100 1 5 5
    63323096198 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID FRESENIUS KABI 1 MG 5 1 4 4
    63323096600 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID FRESENIUS KABI 1 MG 100 1 5 5
    67457039054 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID MYLAN INSTITUTIONAL LLC 1 MG 5 1 4 4
    67457061910 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID MYLAN INSTITUTIONAL LLC 1 MG 100 1 5 5
    67457079410 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID MYLAN INSTITUTIONAL LLC 1 MG 100 1 5 5
    67457092005 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID MYLAN INSTITUTIONAL LLC 1 MG 5 1 4 4
    68001043725 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID BLUEPOINT LABORATORIES 1 MG 5 1 4 4
    70860021051 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID ATHENEX 1 MG 100 1 4 4
    70860080282 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID ATHENEX 1 MG 100 1 5 5
    71288080651 J3489 Zoledronic acid 1mg ZOLEDRONIC ACID MEITHEAL PHARMACEUTICALS, INC. 1 MG 100 1 5 5
    72266015201 J3489 Zoledronic acid 1mg Zoledronic Acid FOSUN PHARMA USA INC. 1 MG 100 1 5 5
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 1 MG
    HCPCS/CPT Billing Units 1
    Total doses ordered
    Billing Units 1

    Drug Details

    • Zoledronic acid (Reclast) is used to prevent or treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause ('change of life,' end of regular menstrual periods). Zoledronic acid (Reclast) is also used to treat osteoporosis in men, and to prevent or treat osteoporosis in men and women who are taking glucocorticoids (a type of corticosteroid medication that may cause osteoporosis). Zoledronic acid (Reclast) is also used to treat Paget's disease of bone (a condition in which the bones are soft and weak and may be deformed, painful, or easily broken). Zoledronic acid (Zometa) is used to treat high levels of calcium in the blood that may be caused by certain types of cancer. Zoledronic acid (Zometa) is also used along with cancer chemotherapy to treat bone damage caused by multiple myeloma [cancer that begins in the plasma cells (white blood cells that produce substances needed to fight infection)] or by cancer that began in another part of the body but has spread to the bones. Zoledronic acid (Zometa) is not cancer chemotherapy, and it will not slow or stop the spread of cancer. However, it can be used to treat bone disease in patients who have cancer. Zoledronic acid is in a class of medications called bisphosphonates. It works by slowing bone breakdown, increasing bone density (thickness), and decreasing the amount of calcium released from the bones into the blood.